Related Experiment Video
Updated: Jun 7, 2025
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
Symptom Screening Linked to Care Pathways for Pediatric Patients With Cancer: A Randomized Clinical Trial
L Lee Dupuis1,2, Emily Vettese1, Allison C Grimes3
1Program in Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada.
Insights
Routine symptom screening significantly improved symptom scores in pediatric cancer patients. This approach led to better symptom management but also increased emergency department visits.
Area of Science:
- Pediatric Oncology
- Symptom Management
- Clinical Trials
Background:
- Pediatric cancer patients frequently experience severe symptoms.
- The efficacy of routine symptom screening and management pathways is not well-established.
Purpose of the Study:
- To evaluate if thrice-weekly symptom screening with feedback and management care pathways improves symptom scores in pediatric cancer patients compared to usual care.
Main Methods:
- A cluster randomized trial involving 445 pediatric cancer patients (aged 8-18) across 20 US centers.
- Intervention group received thrice-weekly symptom screening, alerts, and care pathways; control group received usual care.
- Primary outcome: Symptom Screening in Pediatrics Tool (SSPedi) score at 8 weeks.
Main Results:
- Symptom screening group had significantly lower SSPedi scores at 8 weeks (adjusted mean difference: -3.8).
- 12 of 15 individual symptoms were significantly reduced in the screening group.
- No difference in fatigue or quality of life; however, the screening group had more emergency department visits (rate ratio: 1.72).
Conclusions:
- Symptom screening with feedback and management pathways improves symptom scores and interventions in pediatric cancer patients.
- Integration of symptom screening into routine clinical care is recommended.
- Increased emergency department visits warrant further investigation.
Importance:
Pediatric patients with cancer commonly experience severely bothersome symptoms. The effectiveness of routine symptom screening with symptom feedback and symptom management care pathways is unknown.
Objective:
To determine whether thrice-weekly symptom screening with symptom feedback and management care pathways, compared with usual care, improves overall self-reported symptom scores measured by the Symptom Screening in Pediatrics Tool (SSPedi) in pediatric patients with cancer.
Design, Setting, And Participants:
This cluster randomized trial enrolled participants between July 2021 and August 2023 from 20 pediatric cancer centers in the US. Patients newly diagnosed with cancer aged 8 to 18 years receiving any cancer treatment were included. Twenty sites were randomized to provide symptom screening (n = 10) vs usual care (n = 10); 221 participants were enrolled at intervention sites and 224 participants at control sites. The date of final follow-up was October 18, 2023.
Intervention:
Symptom screening included providing thrice-weekly symptom screening prompts to participants, email alerts to the health care team, and locally adapted symptom management care pathway implementation.
Main Outcomes And Measures:
The primary outcome was self-reported total SSPedi score at week 8 (range, 0-60; higher scores indicate more bothersome). Secondary outcomes were Patient-Reported Outcomes Measurement Information System Fatigue score (mean [SD] score, 50 [10]; higher scores indicate more fatigue), Pediatric Quality of Life 3.0 Acute Cancer Module scores (range, 0-100; higher scores indicate better health), symptom documentation and interventions at week 8, and unplanned health care encounters.
Results:
A total of 445 participants (median [range] age, 14.8 [8.1-18.9] years; 58.9% males) were enrolled. The mean (SD) 8-week SSPedi score was 7.9 (7.2) in the symptom screening group vs 11.4 (8.7) in the usual care group. Symptom screening was associated with significantly better 8-week total SSPedi scores (adjusted mean difference, -3.8 [95% CI, -6.4 to -1.2]) and less bothersome individual symptoms, with 12 of 15 symptoms being statistically significantly reduced. There was no difference in fatigue or quality of life. The mean (SD) number of emergency department visits was 0.77 (1.12) in the symptom screening group and 0.45 (0.81) in the usual care group. There were significantly more emergency department visits in the symptom screening group (rate ratio, 1.72 [95% CI, 1.03-2.87]).
Conclusions:
Symptom screening with symptom feedback and symptom management care pathways was associated with improved symptom scores and increased symptom-specific interventions. Future work should integrate symptom screening into routine clinical care.
Trial Registration:
ClinicalTrials.gov Identifier: NCT04614662.
Related Concept Videos
01:30Preventive Healthcare Services
01:21Cancer Survival Analysis
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...